Cargando…

A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry

Objectives: Exosomes are the smallest of the extracellular vesicles and can contain a variety of different cargos, including nucleic acids, lipids, and proteins. Ultracentrifugation followed by electron microscopy has historically been used for the isolation and visualization of exosomes; Western bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Alejandre Gonzalez, Alan Guillermo, Ortiz-Lazareno, Pablo Cesar, Solorzano-Ibarra, Fabiola, Gutierrez-Franco, Jorge, Tellez-Bañuelos, Martha Cecilia, Bueno-Topete, Miriam Ruth, del Toro-Arreola, Susana, Haramati, Jesse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192796/
https://www.ncbi.nlm.nih.gov/pubmed/37186801
http://dx.doi.org/10.1177/15330338221150324
_version_ 1785043703722672128
author Alejandre Gonzalez, Alan Guillermo
Ortiz-Lazareno, Pablo Cesar
Solorzano-Ibarra, Fabiola
Gutierrez-Franco, Jorge
Tellez-Bañuelos, Martha Cecilia
Bueno-Topete, Miriam Ruth
del Toro-Arreola, Susana
Haramati, Jesse
author_facet Alejandre Gonzalez, Alan Guillermo
Ortiz-Lazareno, Pablo Cesar
Solorzano-Ibarra, Fabiola
Gutierrez-Franco, Jorge
Tellez-Bañuelos, Martha Cecilia
Bueno-Topete, Miriam Ruth
del Toro-Arreola, Susana
Haramati, Jesse
author_sort Alejandre Gonzalez, Alan Guillermo
collection PubMed
description Objectives: Exosomes are the smallest of the extracellular vesicles and can contain a variety of different cargos, including nucleic acids, lipids, and proteins. Ultracentrifugation followed by electron microscopy has historically been used for the isolation and visualization of exosomes; Western blot and ELISA have also been used, but these techniques are only semiquantitative and are unable to distinguish different exosome markers in the same sample. To resolve some of these issues, we propose a modification of a bead-based flow cytometry method. Methods: Peripheral blood serum was mixed with a commercial exosome separation reagent and incubated for 30 min at 4°, centrifuged, exosome pellet was isolated and resuspended in PBS. Exosomes were then added to magnetic beads, incubated 18 h, then incubated with exosome-specific antibodies for 1 h. The resulting bead:exosome complexes were centrifuged and then washed, then washed again using a magnetic separator, resuspended in PBS, and analyzed via flow cytometry. Results: Using commercial magnetic beads bound with anti-CD63, our protocol modifies starting conditions, washing steps, and magnetic separation and uses the FSC and SSC determination of the flow cytometer to result in increased yield and identification of the exosome populations of interest. Our modified protocol increased the yield of specific populations approximately 10-fold. Conclusion: The new protocol was used to identify exosomes positive for 2 immune checkpoint ligands in serum-derived exosomes from cervical cancer patients. We suspect that this protocol can also be used for the identification of other exosome proteins since we also quantified the exosome membrane-enriched tetraspanins CD9 and CD81. Identification of proteins rarely expressed in exosomes is complicated in this technique as serum is an inherently dirty source of exosomes, and great care must be taken in the washing and gating of the exosome:bead populations.
format Online
Article
Text
id pubmed-10192796
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-101927962023-05-19 A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry Alejandre Gonzalez, Alan Guillermo Ortiz-Lazareno, Pablo Cesar Solorzano-Ibarra, Fabiola Gutierrez-Franco, Jorge Tellez-Bañuelos, Martha Cecilia Bueno-Topete, Miriam Ruth del Toro-Arreola, Susana Haramati, Jesse Technol Cancer Res Treat Emerging roles of Extracellular Vesicles in cancer research and therapy Objectives: Exosomes are the smallest of the extracellular vesicles and can contain a variety of different cargos, including nucleic acids, lipids, and proteins. Ultracentrifugation followed by electron microscopy has historically been used for the isolation and visualization of exosomes; Western blot and ELISA have also been used, but these techniques are only semiquantitative and are unable to distinguish different exosome markers in the same sample. To resolve some of these issues, we propose a modification of a bead-based flow cytometry method. Methods: Peripheral blood serum was mixed with a commercial exosome separation reagent and incubated for 30 min at 4°, centrifuged, exosome pellet was isolated and resuspended in PBS. Exosomes were then added to magnetic beads, incubated 18 h, then incubated with exosome-specific antibodies for 1 h. The resulting bead:exosome complexes were centrifuged and then washed, then washed again using a magnetic separator, resuspended in PBS, and analyzed via flow cytometry. Results: Using commercial magnetic beads bound with anti-CD63, our protocol modifies starting conditions, washing steps, and magnetic separation and uses the FSC and SSC determination of the flow cytometer to result in increased yield and identification of the exosome populations of interest. Our modified protocol increased the yield of specific populations approximately 10-fold. Conclusion: The new protocol was used to identify exosomes positive for 2 immune checkpoint ligands in serum-derived exosomes from cervical cancer patients. We suspect that this protocol can also be used for the identification of other exosome proteins since we also quantified the exosome membrane-enriched tetraspanins CD9 and CD81. Identification of proteins rarely expressed in exosomes is complicated in this technique as serum is an inherently dirty source of exosomes, and great care must be taken in the washing and gating of the exosome:bead populations. SAGE Publications 2023-05-15 /pmc/articles/PMC10192796/ /pubmed/37186801 http://dx.doi.org/10.1177/15330338221150324 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Emerging roles of Extracellular Vesicles in cancer research and therapy
Alejandre Gonzalez, Alan Guillermo
Ortiz-Lazareno, Pablo Cesar
Solorzano-Ibarra, Fabiola
Gutierrez-Franco, Jorge
Tellez-Bañuelos, Martha Cecilia
Bueno-Topete, Miriam Ruth
del Toro-Arreola, Susana
Haramati, Jesse
A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
title A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
title_full A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
title_fullStr A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
title_full_unstemmed A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
title_short A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
title_sort modified method for the quantification of immune checkpoint ligands on exosomes from human serum using flow cytometry
topic Emerging roles of Extracellular Vesicles in cancer research and therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192796/
https://www.ncbi.nlm.nih.gov/pubmed/37186801
http://dx.doi.org/10.1177/15330338221150324
work_keys_str_mv AT alejandregonzalezalanguillermo amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT ortizlazarenopablocesar amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT solorzanoibarrafabiola amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT gutierrezfrancojorge amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT tellezbanuelosmarthacecilia amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT buenotopetemiriamruth amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT deltoroarreolasusana amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT haramatijesse amodifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT alejandregonzalezalanguillermo modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT ortizlazarenopablocesar modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT solorzanoibarrafabiola modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT gutierrezfrancojorge modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT tellezbanuelosmarthacecilia modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT buenotopetemiriamruth modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT deltoroarreolasusana modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry
AT haramatijesse modifiedmethodforthequantificationofimmunecheckpointligandsonexosomesfromhumanserumusingflowcytometry